Featured Research

from universities, journals, and other organizations

Hypertensive rat genome sequence expected to uncover genetic basis of human hypertension

Date:
May 3, 2010
Source:
Cold Spring Harbor Laboratory
Summary:
Chronic high blood pressure, also known as hypertension, is a serious health risk factor that afflicts more than 25 percent of all adults worldwide, but the molecular basis of the disease remains poorly understood. In a new study, scientists have sequenced the genome of the spontaneously hypertensive rat, building a rich catalog of genetic variants that will help researchers to understand causes of the disease in humans.

Chronic high blood pressure, also known as hypertension, is a serious health risk factor that afflicts more than 25% of all adults worldwide, but the molecular basis of the disease remains poorly understood. In a study published online April 28 in Genome Research scientists have sequenced the genome of the spontaneously hypertensive rat, building a rich catalog of genetic variants that will help researchers to understand causes of the disease in humans.

The spontaneously hypertensive rat (SHR) strain is the most widely studied animal model of human hypertension. Research on this strain has identified many genomic regions that likely harbor genetic variants that are responsible for the hypertension phenotype, however without a complete sequence of the hypertensive rat genome, it has been difficult to resolve many of these genomic changes and explore their molecular consequences.

Taking advantage of new technologies that are rapidly driving down the cost of DNA sequencing, an international team of researchers led by Timothy Aitman of the MRC Clinical Sciences Centre and Imperial College London have sequenced the first genome of a mammalian disease model with second-generation sequencing technology. By comparing the SHR genome sequence with that of the rat reference genome sequence, Aitman and colleagues generated a nearly complete catalog of SHR genomic variants that could contribute to hypertension and other phenotypes. They also found that genes known to be abnormally expressed in SHR are especially enriched for sequence variants.

The group expected that the genome sequence would reveal mutations disrupting a number of genes in the SHR strain, however the number of mutated genes they found was quite surprising -- 788 genes are mutated in SHR compared to the reference genome, including 60 that are deleted altogether. "So many major differences in protein sequence were unexpected because of the previous belief that differences in a small number of genes and proteins would be responsible for the phenotypic differences between such rat strains," said Aitman.

Of the 788 mutated genes identified in the SHR genome, many are related to cellular functions such as ion transport and plasma membrane localization, as well as immunological and neurological processes. The authors suggest that defects in these functional categories may be causally associated with the known phenotypes of this strain.

Aitman explained that their characterization of genetic variation in the hypertensive rat would be invaluable for complete elucidation of the causes of hypertension and related traits at the molecular level in hypertensive rat. "This in turn will pave the way for greater understanding of the genetic basis of hypertension in humans," Aitman noted, "a problem that has proved remarkably difficult to study in humans directly."


Story Source:

The above story is based on materials provided by Cold Spring Harbor Laboratory. Note: Materials may be edited for content and length.


Journal Reference:

  1. Atanur SS, Birol I, Guryev V, Hirst M, Hummel O, Morrissey C, Behmoaras J, Fernadez-Suarez XM, Johnson MD, McLaren WM, et al. The genome sequence of the spontaneously hypertensive rat: Analysis and functional significance. Genome Res, April 29, 2010 DOI: 10.1101/gr.103499.109

Cite This Page:

Cold Spring Harbor Laboratory. "Hypertensive rat genome sequence expected to uncover genetic basis of human hypertension." ScienceDaily. ScienceDaily, 3 May 2010. <www.sciencedaily.com/releases/2010/04/100428173328.htm>.
Cold Spring Harbor Laboratory. (2010, May 3). Hypertensive rat genome sequence expected to uncover genetic basis of human hypertension. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100428173328.htm
Cold Spring Harbor Laboratory. "Hypertensive rat genome sequence expected to uncover genetic basis of human hypertension." ScienceDaily. www.sciencedaily.com/releases/2010/04/100428173328.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins